Stefanie L. Cavanaugh - 07 Jul 2021 Form 4 Insider Report for Apollo Endosurgery, Inc.

Role: CFO, Treasurer, Secretary
Signature: /s/ Brian Szymczak - Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 07 Jul 2021
Net transactions value: $0
Form type: 4
Filing time: 07 Jul 2021, 16:27:52 UTC
Next filing: 18 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APEN	Common Stock	Other	$0	+91	+0.09%	$0.000000	95,998	07 Jul 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of the Issuer's common stock paid as interest on $25,750 aggregate principal amount of the Reporting Person's 6.0% Convertible Debentures, or the Notes, previously reported, for the interest payment period from and including January 1, 2021, to, but excluding, July 1, 2021. Interest on the Notes is payable semi-annually in shares of the Issuer's common stock on January 1 and July 1 of each year at a rate of 6.00% per year and based on the volume-weighted average price of the Issuer's common stock for the 10 consecutive trading days immediately preceding the applicable interest payment date.

Content

Represents shares of the Issuer's common stock paid as interest on $25,750 aggregate principal amount of the Reporting Person's 6.0% Convertible Debentures, or the Notes, previously reported, for the interest payment period from and including January 1, 2021, to, but excluding, July 1, 2021. Interest on the Notes is payable semi-annually in shares of the Issuer's common stock on January 1 and July 1 of each year at a rate of 6.00% per year and based on the volume-weighted average price of the Issuer's common stock for the 10 consecutive trading days immediately preceding the applicable interest payment date.